4th Quarter - Amendment

SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING for SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Firm
Client
Income
—
Expenses
$60,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report Jan 11, 2017 $60,000 Replaced
4th Quarter - Amendment (this page) Jan 11, 2017 $60,000 Yes

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Nuclear medicine reimbursement generally and nuclear medicine APC's under HOPPS and appropriate use criteria under the MPFS specifically.

LobbyistCovered position, as disclosed
CAITLIN BLAKE KUBLER —

Contacted: HOUSE OF REPRESENTATIVES; Office of Science & Technology Policy (OSTP); Nuclear Regulatory Commission (NRC); Food & Drug Administration (FDA); Veterans Affairs, Dept of (VA); SENATE; Energy, Dept of; Centers For Medicare and Medicaid Services (CMS)

Health Issues HCR

The 21st Century Cures Act(HR 6) generally; and the creation of a new imaging drug approval pathway at the FDA specifically. Issues relating to a proposal at the Veterans Administration changing the practice of advanced nursing as it relates to imaging.

LobbyistCovered position, as disclosed
CAITLIN BLAKE KUBLER —

Contacted: SENATE; Energy, Dept of; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Nuclear Regulatory Commission (NRC); Centers For Medicare and Medicaid Services (CMS); Veterans Affairs, Dept of (VA); Office of Science & Technology Policy (OSTP)

Bills named: H.R. 6 (114th)

Pharmacy PHA

Implementation of the radiopharmaceutical provisions of The Drug Quality and Security Act as it relates to compounding.

LobbyistCovered position, as disclosed
CAITLIN BLAKE KUBLER —

Contacted: SENATE; Veterans Affairs, Dept of (VA); Office of Science & Technology Policy (OSTP); Food & Drug Administration (FDA); Energy, Dept of; HOUSE OF REPRESENTATIVES; Nuclear Regulatory Commission (NRC); Centers For Medicare and Medicaid Services (CMS)

Energy/Nuclear ENG

Domestic isotope supply issues generally, including oversight of the American Medical Isotope Production Act of 2011. Medical radiation issues generally, including Nuclear Regulatory Commission regulations.

LobbyistCovered position, as disclosed
CAITLIN BLAKE KUBLER —

Contacted: Centers For Medicare and Medicaid Services (CMS); Nuclear Regulatory Commission (NRC); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE; Energy, Dept of; Veterans Affairs, Dept of (VA); Office of Science & Technology Policy (OSTP)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.